Since Reata Pharmaceuticals was founded in 2002, it has participated in 8 rounds of funding. In total Reata Pharmaceuticals has raised $791.9M. Reata Pharmaceuticals' last funding round was on May 2023 for a total of $137.5M.
Reata Pharmaceuticals has 4 investors, including BioPharma Credit Investments, Silicon Valley Bank and Oxford Finance. The latest investment occurred in May 2023.
